Used as a potent and selective antagonist for the GABAA receptor subtype, particularly targeting α5 subunit-containing receptors. This compound is primarily utilized in neuroscience research to study cognitive functions, memory modulation, and anxiety-related pathways. It has shown potential in reversing sedative effects and improving learning and memory in preclinical models. Due to its ability to cross the blood-brain barrier effectively, it serves as a valuable tool compound in the development of nootropic and pro-cognitive agents. It is also employed in structure-activity relationship (SAR) studies for designing new pyrazolopyrimidine-based therapeutics targeting central nervous system disorders.